Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT06823414RecruitingBreast Cancer Non-invasive Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | High Risk Breast Carcinoma
-
NCT06224673Not yet recruitingARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerTriple Negative Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast Cancer
-
NCT00071942TerminatedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00003440CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast Cancer
-
NCT06590558WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma | Locally Advanced HER2-Negative Breast Carcinoma
-
NCT03039140CompletedStage 0 Breast Cancer | Cancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer
-
NCT02370264TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Musculoskeletal Complication
-
NCT01351909Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast Carcinoma
-
NCT03455270CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer Female
-
NCT07486687Not yet recruitingBreast Cancer Stage II | Breast Cancer Stage III | Triple -Negative Breast Cancer | Early Stage Triple-Negative Breast Carcinoma | Triple Negative Breast Cancer (TNBC), Early Setting
-
NCT01153672CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
-
NCT05035745RecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast Cancers
-
NCT04088110Not yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
-
NCT05198843TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Inflammatory Carcinoma
-
NCT00577122CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer
-
NCT01755208TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Healthy, no Evidence of Disease
-
NCT02186470CompletedStage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Invasive Ductal Breast Carcinoma | Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate | Mucinous Ductal Breast Carcinoma | Papillary Ductal Breast Carcinoma | Tubular Ductal Breast Carcinoma | Invasive Ductal Breast Carcinoma With Predominant Intraductal Component
-
NCT03774472CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
-
NCT04876378TerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
-
NCT06827236RecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma
-
NCT06610097RecruitingBreast Cancer | Triple Negative Breast Cancer | Early Stage Triple-Negative Breast Carcinoma
-
-
NCT06281210RecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Neoadjuvant Chemotherapy
-
NCT04088032WithdrawnLocally Advanced Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female
-
NCT01876238CompletedAdvanced Breast Cancer | Recurrent Breast Cancer | Stage 4 Breast Cancer
-
NCT06476119RecruitingBreast Cancer Stage I | Triple Negative Breast Cancer (TNBC)
-
NCT06358573RecruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer
-
NCT05115474RecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor-positive Breast Cancer
-
NCT06439940RecruitingBreast Cancer | Breast Carcinoma | Breast Cancer Female
-
NCT04608357RecruitingBreast Cancer | Breast Neoplasms | Metastatic Breast Cancer | Cancer, Breast
-
NCT07421141Active, not recruitingBreast Cancer | HER2-positive Breast Cancer | Early Breast Cancer
-
NCT06112795CompletedBreast Cancer | Breast Carcinoma | Breast Cancer Female
-
-
NCT06890871Enrolling by invitationBreast Cancer, Metastatic Breast Cancer
-
NCT01980823CompletedBreast Cancer | Breast Tumors | Cancer of Breast
-
NCT02632071CompletedMetastatic Breast Cancer | Breast Carcinoma
-
NCT02424682CompletedBreast Cancer, Metastatic Breast Cancer
-
NCT04294225CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
-
NCT04260620CompletedBreast Cancer Detection | Dense Breast Parenchyma | Benign Breast Findings | Normal Breast Screening | Abnormal Breast Screening
-
NCT03012100Active, not recruitingTriple-Negative Breast Carcinoma | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast Inflammatory Carcinoma
-
NCT05346861RecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer
-
NCT04318223RecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer
-
NCT05486520Enrolling by invitationMalignant Neoplasm of Breast | Breast Benign | Breast Malignant Tumor
-
NCT05721248Active, not recruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer
-
NCT03368729Active, not recruitingMetastatic Breast Cancer | HER2 Positive Breast Carcinoma
-
NCT05963984CompletedBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer
-
NCT02199366Completed
-
NCT05021900CompletedMetastatic Breast Cancer | Locally Advanced Breast Cancer
-
NCT05812326CompletedAdvanced Breast Cancer | Breast Neoplasm Malignant Female
-
NCT03045289CompletedMetastatic Breast Cancer | Breast Cancer Stage IV
-
NCT03698383UnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast Cancer